Published in AIDS Res Hum Retroviruses on October 15, 2010
Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85
Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther (2012) 1.71
Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing. BMC Infect Dis (2013) 0.95
Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi. AIDS Res Ther (2011) 0.77
RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics (2006) 87.59
Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res (2003) 10.50
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS (2006) 5.31
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol (2005) 2.61
Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Antivir Ther (2008) 1.74
Death by deamination: a novel host restriction system for HIV-1. Cell (2003) 1.71
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes. AIDS (2006) 1.40
Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals. AIDS Res Hum Retroviruses (2006) 1.17
Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. AIDS Res Hum Retroviruses (2005) 1.14
Early evolution of the human immunodeficiency virus type 1 subtype C epidemic in rural Malawi. J Virol (2002) 1.10
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. AIDS Res Hum Retroviruses (2003) 1.10
Molecular epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia. AIDS Res Hum Retroviruses (2007) 1.02
HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi. AIDS Res Hum Retroviruses (2007) 0.92
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56
Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med (2010) 6.56
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet (2008) 5.93
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2011) 5.34
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med (2007) 4.56
Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol (2004) 4.03
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet (2002) 3.75
How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis (2004) 3.50
CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31
The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med (2011) 3.25
Trends and measurement of HIV prevalence in northern Malawi. AIDS (2003) 3.24
The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One (2011) 3.21
Educational attainment and HIV-1 infection in developing countries: a systematic review. Trop Med Int Health (2002) 2.80
Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis (2010) 2.72
Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS (2008) 2.67
Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol (2004) 2.55
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54
Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis (2002) 2.54
Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi. PLoS One (2010) 2.36
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis (2011) 2.32
The effects of high HIV prevalence on orphanhood and living arrangements of children in Malawi, Tanzania, and South Africa. Popul Stud (Camb) (2007) 2.24
HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS (2004) 2.12
Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12
Updates to the spectrum model to estimate key HIV indicators for adults and children. AIDS (2014) 2.09
Underestimation of HIV prevalence in surveys when some people already know their status, and ways to reduce the bias. AIDS (2013) 2.06
From affected to infected? Orphanhood and HIV risk among female adolescents in urban Zimbabwe. AIDS (2008) 2.06
HIV and mortality of mothers and children: evidence from cohort studies in Uganda, Tanzania, and Malawi. Epidemiology (2005) 2.04
Herpes simplex virus type 2: a key role in HIV incidence. AIDS (2009) 2.03
Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS (2007) 1.93
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Estimating 'net' HIV-related mortality and the importance of background mortality rates. AIDS (2007) 1.90
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics. Sex Transm Infect (2007) 1.89
The role of context: neighbourhood characteristics strongly influence HIV risk in young women in Ndola, Zambia. Trop Med Int Health (2008) 1.89
Age-specific mortality patterns in HIV-infected individuals: a comparative analysis of African community study data. AIDS (2007) 1.87
Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ (2004) 1.86
Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol (2012) 1.85
The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS (2003) 1.83
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis (2007) 1.79
A novel method for detecting intramolecular coevolution: adding a further dimension to selective constraints analyses. Genetics (2006) 1.77
High accuracy of home-based community rapid HIV testing in rural Malawi. J Acquir Immune Defic Syndr (2010) 1.73
Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa. Trop Med Int Health (2012) 1.62
Assessing the safety of stem cell therapeutics. Cell Stem Cell (2011) 1.60
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect (2007) 1.60
InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries. Glob Health Action (2013) 1.59
Use of data from HIV counselling and testing services for HIV surveillance in Africa. Lancet (2007) 1.54
Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS (2010) 1.52
What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health (2010) 1.51
Is education the link between orphanhood and HIV/HSV-2 risk among female adolescents in urban Zimbabwe? Soc Sci Med (2009) 1.50
Tuberculosis transmission attributable to close contacts and HIV status, Malawi. Emerg Infect Dis (2006) 1.49
Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners. AIDS (2007) 1.48
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr (2008) 1.48
Individual, household and community factors associated with HIV test refusal in rural Malawi. Trop Med Int Health (2008) 1.41
Measuring concurrency: an empirical study of different methods in a large population-based survey and evaluation of the UNAIDS guidelines. AIDS (2012) 1.40
Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One (2011) 1.39
Age at menarche, schooling, and sexual debut in northern Malawi. PLoS One (2010) 1.39
Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi. PLoS One (2011) 1.38
The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health (2012) 1.38
Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health (2012) 1.38
Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis (2012) 1.38
Molecular detection of mixed infections of Mycobacterium tuberculosis strains in sputum samples from patients in Karonga District, Malawi. J Clin Microbiol (2010) 1.33
Invasive group B streptococcal infection in infants, Malawi. Emerg Infect Dis (2007) 1.31
Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis (2003) 1.30
Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr (2006) 1.29
Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. Pediatr Infect Dis J (2003) 1.28
HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. AIDS (2004) 1.21
Interactions between HIV and malaria in non-pregnant adults: evidence and implications. AIDS (2006) 1.20
Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis (2012) 1.19
A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation. Trop Med Int Health (2009) 1.16
Point-of-use water treatment and use among mothers in Malawi. Emerg Infect Dis (2007) 1.15
Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen. J Virol (2012) 1.15
CD209 genetic polymorphism and tuberculosis disease. PLoS One (2008) 1.14
Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi. AIDS (2002) 1.13
The long-term social and economic impact of HIV on the spouses of infected individuals in northern Malawi. Trop Med Int Health (2008) 1.13